Listing 1 - 10 of 14 | << page >> |
Sort by
|
Choose an application
Printed Edition of the Special Issue Published in Viruses.
Choose an application
Choose an application
Cytomegalovirus (CMV) is carried by 50 100% of the worlds population throughout their lives. Consequences are most readily seen in immunocompromised individuals such as organ transplant recipients, HIV-infected patients and new born infants. This book gives an in-depth view of manifestations of CMV infection in immunocompromised individuals: how it affects the immune system and how it is diagnosed and treated. The book also sheds light on the epidemiology and impact of CMV in sub-Saharan Africa, and also associations with age related disease that are more commonly seen in the western world. It particularly details a recent discovery between CMV and tumour immuno-biology. The book explores the development of a few compounds and also highlights the need to discover novel antiviral agents in future.
Cytomegalovirus infections. --- CMV infections --- Cytomegalovirus disease --- Herpesvirus diseases --- Infectious & contagious diseases
Choose an application
Increasing age has been associated with an insufficient protection following vaccination and an increased incidence and severity of infectious diseases. The predicted acceleration of global population aging will accentuate the need to understand the mechanisms that drive the age-related decline of the immune system and to, eventually, identify strategies to lower the burden of infectious diseases in elderly people. One type of immune cell appears to be most dramatically affected by the aging process: T lymphocytes. Age-related changes of the bone marrow and the thymus microenvironment lead to a decreased thymic output of functional, naïve T lymphocytes. As T lymphocytes are key players of the adaptive immune system, this research topic will summarize our current understanding on how aging affects the microenvironmental niches and molecular networks that are important for the generation, survival and function of naïve, memory and effector T lymphocytes. This research topic will also address the impact of aging on the different T lymphocyte lineages, such as regulatory T cells and Th17 cells and how age-related changes of the microenvironment affect organ- and tissue-resident memory T lymphocytes. Eventually, the identification of a set of markers for immunosenescence would facilitate the design and application of more specific therapies and improved vaccines and vaccination strategies for elderly people, thereby increasing life and health span.
Aging. --- T cells --- Receptors. --- Autoimmunity --- Cytomegalovirus --- Regulatory T Cell --- Vaccination --- Aging --- Influenza Virus --- biomarker --- health span
Choose an application
Suicide is a complex phenomenon that is now considered understood as a neurodevelopmental condition encompassing childhood experiences as well as proximal conditions such as mental disorders and adverse life events. Individuals in crisis may face overwhelming psychological pain, which in some cases may overcome the threshold of each unique individual for whom suicide is considered the best option to deal with such pain. However, many socio-demographic, personal, or temperamental variables have been investigated for their causal association with suicide risk, but to date no single factor has clearly demonstrated an association with suicide. The mental disorders most frequently associated with suicide risk include bipolar disorders and major unipolar depression, substance use disorders and schizophrenia. However, anxiety, personality, eating, and trauma-related disorders, as well as organic mental disorders, also contribute to suicidal risk. Moreover, in modern society, the presence of social uncertainty, the changes in family models, the development of social media, and the loss of face-to-face interaction can have an impact on suicide risk, particularly in the younger generation.
demoralization --- schizophrenia --- suicide risk --- suicide suicidality personality disorder --- borderline personality disorder --- self-harm --- psychodynamic psychotherapy --- integrative --- suicide --- therapeutic alliance --- countertransference --- hope --- antipsychotics --- depression --- bipolar --- affective temperament --- violent suicide --- aggressive behaviors --- bipolar disorder --- mood disorders --- suicidal --- mortality --- anhedonia --- PTSD --- suicidal behavior --- suicidal ideation --- suicide attempt --- meaning in life --- suicide protective factors --- rational suicide --- old age --- late life --- aging --- ageism --- CMV --- cytomegalovirus --- biomarker --- antibodies --- review
Choose an application
The innate immune system is the first line of defense against bacterial and viral infections and sterile inflammation through the recognition of pathogen-associated molecular patterns (PAMPs) by pathogen recognition receptors (PRRs) resulting in the production of proinflammatory and antiviral cytokines and chemokines. Several damage-associated molecular patterns (DAMPs), which were released by passive or active mechanisms under sterile conditions, are additionally recognized by PRRs and can cause or even aggravate the inflammatory response. In this special issue many aspects of innate immunity are summarized. Mechanisms of different DAMPs to induce pro- and anti-inflammatory activities, functions of different immune cells, as well as the crosstalk between coagulation and innate immunity were described. Furthermore, aspects of autoinflammatory diseases, types of programmed cell death pathways, and insect immunity are covered. Finally, therapeutic options for the treatment of diseases related to autoimmunity or infections are suggested. Overall, this special issue presents a broad overview of activities related to sterile inflammation and defense mechanisms of innate immunity.
Medicine --- inflammation --- type I interferons --- interleukin-1β --- crosstalk --- hepatic non-parenchymal cells --- albumin --- chronic liver diseases --- bacteria --- cytomegalovirus --- endothelin receptor --- repurposing --- cell culture --- Drosophila suzukii --- hemocytes --- plasmatocytes --- extracellular traps --- HMGB1 --- RAGE --- TLR4 --- DAMP --- SIRT1 --- α7-nicotinic acetylcholine receptor --- nociceptor --- cancer --- COVID-19 --- proteostasis --- autoinflammation --- ribosomopathies --- proteinopathies --- proteasomopathies --- extracellular RNA --- cytokines --- macrophages --- endothelial cells --- toll-like receptors --- angiogenesis --- γδ T cells --- gamma delta T cells --- proliferation --- macrophage polarization --- neutrophils --- neutrophil extracellular traps --- NETs --- ischemia --- PANoptosis --- PANoptosome --- pyroptosis --- apoptosis --- necroptosis --- inflammatory cell death --- inflammasome --- innate immunity --- infection --- NLR --- caspase --- IRF1 --- ZBP1 --- RIPK1 --- RIPK3 --- MLKL --- NLRP3 --- AIM2 --- Pyrin --- caspase-1 --- ASC --- caspase-8 --- caspase-3 --- caspase-7 --- plasticity --- redundancy --- SMOC1 --- thrombin --- n/a
Choose an application
Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) has spread worldwide from the beginning of 2020. The infection is mostly asymptomatic but some patients may develop COVID‑19 (coronavirus disease 2019) with a severe or critical course leading to pneumonia, acute respiratory distress syndrome, and multiorgan failure. Apart from the virus‑related damage of the lungs, pathomechanism of the disease seems to be linked to thromboembolism and inflammation accompanied by overproduction of proinflammatory cytokines, termed a cytokine storm, responsible for multiorgan damage and death. Since the development of a new therapeutic molecule, dedicated strictly to a particular virus is time‑consuming, physicians and scientists have started to test and repurpose old medications. Unfortunately, after one year of pandemics, there is still a lack of optimal therapy and no clear indicators of recovery. A major issue is also insufficient knowledge on predictors of the severe or deadly course of the disease, which could also help to switch from one therapeutic option to another. Due to many gaps still existing in the management of COVID-19, there is a need for the accumulation of new data particularly from real-world experience, which could be applicable to practice guidelines. The objective of this special issue of the Journal of Clinical Medicine is to provide an update on the mangement for the diagnostic workup and pharmacotherapy of SARS‑CoV‑2 infection.
Medicine --- COVID-19 --- SARS-CoV-2 --- interleukin-6 --- tocilizumab --- therapy --- coronavirus disease 2019 --- cytokines --- severity --- prognosis --- mortality --- kidney failure --- rapid diagnostic test --- antigen detection --- Cytomegalovirus --- co-infections --- critical care --- liver markers --- inflammation --- morbidity --- personalized medicine --- liver functional tests --- COVID-19 pneumonia --- meta-analysis --- trial sequential analysis --- children --- clinical presentation --- coronavirus disease 2019 (COVID-19) --- epidemiology --- severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) --- clinical outcome --- symptomatology --- pandemic --- angiotensin 1 receptor (AT1R) --- AT1R concentration --- angiotensin II --- symptoms’ severity --- diagnosis --- artificial intelligence --- medical imaging --- systematic umbrella review --- methodological credibility --- PCR test --- COVID-19 diagnosis --- Charlson Comorbidities Index --- cluster analysis --- longitudinal cluster --- individualized management --- n/a --- symptoms' severity
Choose an application
The structure, uniformity, stability, and functions of virus-like particles (VLPs) have encouraged scientists to utilize them as a unique tool in various applications in biomedical fields. Their interaction with the innate immune system is of major importance for the adaptive immune response they induce. The innate immune cells and molecules recognize and interact with VLPs on the basis of two major characteristics: size and surface geometry. VLP-based vaccines against hepatitis B, human papilloma, malaria, and hepatitis E have been developed and are available in many countries around the world. Given the inherent immunogenicity of VLPs, they render themselves ideal for the development of new vaccines against infectious diseases as well as noncommunicable diseases, such as chronic inflammation or cancer. This Special Issue is designed to provide an up-to-date view of the latest progress in the development of VLP-based prophylactic and therapeutic vaccines and technologies for their generation.
virus-like particle --- influenza A(H1N1)pdm09 --- vaccination --- pregnant women --- antibody titers --- norovirus --- VLP --- vaccine --- genotype --- pre-existing immunity --- cross-reactivity --- blocking antibodies --- original antigenic sin (OAS) --- HPVs --- vaccines --- virus-like particles (VLPs) --- minor capsid protein (L2) --- HCMV --- cytomegalovirus --- nanoparticle --- immune response --- Sudan virus --- mice --- horse --- purified IgG --- long-lived plasma cells --- antibodies --- multivalency --- virus-like particles --- antigenic analysis --- epitope characterization --- hepatitis E vaccine --- serological evaluation --- virion-like epitopes --- well-characterized vaccines --- hepatitis B virus --- surface (envelope) antigen --- sub-viral particle --- capsid --- antigen display --- platform --- viral quantification --- NTA --- flow virometry --- SRFM --- cryo-TEM --- SEM --- plant virus --- virus-like --- vaccine platform --- epitope --- antigen --- cat allergy --- Fel d 1 --- HypoCat™ --- IL-13 --- interleukin-13 --- Tfh cells --- cancer --- immunotherapy --- H7N9 --- pandemic influenza A --- avian flu --- IAV --- VLP vaccine --- n/a
Choose an application
Since first receiving approval in 1986, antibody-based therapeutics have been the most successful modality for the treatment of various diseases. This Special Issue of IJMS, “Recent Advances in Antibody Therapeutics”, presents leading-edge articles and reviews for discovery, development, and clinical applications of therapeutic antibodies, covering antibody drug conjugates (ADCs), GPCR-targeting antibodies, a functional antibody screening, bioassay of bispecific antibodies, antibody applications for cardiovascular diseases, antibody delivery to CNS, etc. The excellent studies in this Special Issue would valuable insight for scientists and clinicians in the field of therapeutic antibodies
interleukin 33 --- ST2 receptor --- scFv --- C2_2E12 --- bladder cancer --- antibodies --- immune checkpoint inhibitors --- antibody-drug conjugates --- sacituzumab govitecan --- enfortumab vedotin --- erdafitinib --- cost-effectiveness --- G protein-coupled receptor --- membrane protein --- antigen --- therapeutic antibody --- anti-angiogenesis --- delta-like ligand --- irinotecan --- paclitaxel --- VEGF --- SARS-CoV-2 --- spike protein --- receptor-binding domain --- phage display --- monoclonal antibody --- cytomegalovirus --- peptide/major histocompatibility complex class I complex --- T-cell-receptor-like antibody --- affinity maturation --- yeast surface display --- combinatorial antibody library --- agonist antibody --- cell fate --- bispecific antibodies --- bioassays --- mechanisms of action --- binding assays --- potency assays --- atherosclerosis --- inflammation --- antibody therapy --- blood–brain barrier --- antibody --- pharmacokinetics --- disposition --- biochemical and physicochemical properties --- Fc binding --- receptor-mediated transcytosis --- brain shuttle --- molecular Trojan horse --- transferrin --- anti-cancer antibody --- antibody engineering --- biophysical properties --- computational methods --- research cell bank --- antibody therapeutics --- recombinant antibodies --- intracellular antibodies --- single-chain antibody fragment --- nanobody --- Human papillomaviruses --- HPV oncoproteins --- HPV-associated cancer --- HPV cancer therapy --- asthma --- refractory asthma --- biomarker --- n/a --- blood-brain barrier
Choose an application
Human lactation has evolved to produce a milk composition that is uniquely-designed for the human infant. Not only does human milk optimize infant growth and development, it also provides protection from infection and disease. More recently, the importance of human milk and breastfeeding in the programming of infant health has risen to the fore. Anchoring of infant feeding in the developmental origins of health and disease has led to a resurgence of research focused in this area. Milk composition is highly variable both between and within mothers. Indeed the distinct maternal human milk signature, including its own microbiome, is influenced by environmental factors, such as diet, health, body composition and geographic residence. An understanding of these changes will lead to unravelling the adaptation of milk to the environment and its impact on the infant. In terms of the promotion of breastfeeding, health economics and epidemiology is instrumental in shaping public health policy and identifying barriers to breastfeeding. Further, basic research is imperative in order to design evidence-based interventions to improve both breastfeeding duration and women's breastfeeding experience.
Cambodia --- milk metabolomics --- galactogogues --- adequate intake --- postnatal outcomes --- cytomegalovirus --- midwifery --- milk synthesis --- chromatography --- protein --- lactoferrin --- human lactation --- ultrasound skinfolds --- breastfed infants --- knowledge --- pregnancy --- casein --- SEA --- maternal factors --- ethnicity --- post-partum distress --- bottle --- composition --- feeding --- co-sleeping --- passive immunity --- glycerophosphocholine --- anthropometrics --- antimicrobial proteins --- professional support --- mothers of preterm infants --- responsive feeding --- lactating women --- peptidomics --- triiodothyronine --- preterm --- mother–infant physical contact --- expressing --- preterm infant --- appetite regulation --- justification of supplementation --- body composition --- zinc supplementation --- antibodies --- antisecretory factor --- proteolysis --- enteral nutrition --- Ecuador --- growth factors --- maternal responsiveness --- maternal wellbeing --- nipple shield --- microbiome --- maternal distress --- sodium --- thyroid --- maternal diet --- thyroxine --- IgA --- caesarean section --- raw breast milk --- colostrum --- fatty acids --- breast milk --- immune cells --- metabolites --- PEA --- premature --- mode of delivery --- endocannabinoids --- lipids --- practice --- fat synthesis --- attitudes --- feeding cues --- infant --- Docosahexaenoic acid --- Arachidonic acid --- GDM --- milk-acquired infections --- zinc deficiency --- ICP-OES --- social support --- infants --- omega-6 fatty acids --- infant health --- HGF --- omega-3 fatty acids --- OEA --- leptin --- milk metabolites --- Canada --- mother–infant interaction --- NMR spectroscopy --- lipidomics --- infection --- breastfeeding support --- prematurity --- phosphocholine --- immunity --- Quito --- sex-specificity --- choline --- paternal role --- inflammation --- docosahexaenoic acid --- partner support --- proximal care --- thyroid antibodies --- adipokines --- calculated daily intakes --- candida --- proton nuclear magnetic resonance --- N-acylethanolamines --- milk intake --- whey --- bioelectrical impedance spectroscopy --- breastfeeding --- n-6 and n-3 polyunsaturated fatty acid --- babywearing --- milk composition --- breastmilk --- obesity --- lactation --- infant growth --- formula supplementation --- early life nutrition --- adiponectin --- milk cells --- potassium --- human milk --- long-chain polyunsaturated fatty acids --- Andean region --- Ireland --- mass spectrometry --- geographical location --- diet --- dietary recommendations --- TGF-? --- ion selective electrode --- plasma zinc --- barriers --- infant feeding --- human milk composition --- Breastfeeding
Listing 1 - 10 of 14 | << page >> |
Sort by
|